More Nunzia Pharmaceutical Corporation news
Nunzia Pharmaceutical CorporationOTC: NUNZ

Cancelling S8 Shares

May 9, 2019 · Issued by Nunzia Pharmaceutical Corporation

On 6ix: 6ix.com/news/cancelling-s8-shares

The original release is unavailable here.

Nunzia Pharmaceutical Corporation on 6ix

Later from Nunzia Pharmaceutical

  • Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and NutraceuticalsApr 16, 2020
  • Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based TinnitusMay 5, 2020
  • Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMERAug 6, 2021
  • Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia's Medical Supply Division. 8K Filed 08/05/2021Aug 16, 2021
All Nunzia Pharmaceutical news releases↗

Follow Nunzia Pharmaceutical into a list and get an email when it puts out news.

Follow Nunzia Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer